Featured Studies

Are you from Mexico, Central or South America, or India with hydrocephalus, seizures, or an inflammatory condition of the central nervous system without a diagnosis? The National Institutes of Health (NIH) is studying people with cysticercosis and those likely to have cysticercosis. All study related tests and procedures are provided at no cost to you. Travel to and from NIH may be reimbursed.

Crohn's disease is a chronic bowel illness that is a lifelong condition characterized by relapsing inflammation. Although there is no cure for Crohn's disease, researchers at the National Institutes of Health (NIH) are investigating if Vorinostat is safe for people with Crohn's Disease. Participants will receive maintenance therapy with Stelara® after successful treatment with Vorinostat.

Genetic testing sometimes tells a person or family unexpected results. These genetic test results are unrelated to the initial reason why the testing was done. These kinds of results are called "secondary results" or "secondary findings." If you or a member of your family have been given a secondary result please consider partnering with us on this research.

The NIH is seeking children ages 2 and older with a history of eczema to participate in a study to identify better ways to diagnose food allergies. Participants do not need to have food allergies. Through this study, we hope to improve the ways food allergies are diagnosed and managed in children with eczema. Participants will not be charged for any service offered, including medications, and medical insurance is not required.

Researchers at National Institutes of Health (NIH) Clinical Center are recruiting healthy adults, ages 18-50, to undergo an initial assessment to determine if they will qualify for future malaria studies. These future studies may involve evaluation of experimental medications, vaccines, and vaccine strategies to prevent malaria.

The National Institutes of Health (NIH) is conducting a research study of the causes and responses to treating multiple sclerosis (MS) and other brain and spine inflammatory conditions. Join this study if you have MS or a related disease. Although the study does not offer treatment options, your participation may help in future discoveries and inspire hope.

We are looking for people recently diagnosed with Lyme disease to help us answer important questions about the infection. If you have or had the rash associated with acute Lyme disease (erythema migrans), facial palsy, meningitis, heart block, or arthritis; please consider participating in our study.

Researchers at NIH are testing a new therapy in patients diagnosed with colitis due to chronic granulomatous disease (CGD). The research aims to see if restoring the gut microbiome reduces inflammation in the colon.